BioSpace News Archive

Ocugen, Inc., (NASDAQ: OCGN), a leading biopharmaceutical company, and Bharat Biotech, a global leader in vaccine innovation, today announced that the companies have signed a binding letter of intent (LOI) to co-develop Bharat Biotech’s COVID-19 vaccine candidate, COVAXIN™, an advanced stage whole-viron inactivated vaccine candidate, for the United States market

Hepion Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has accepted its investigational new drug application for CRV431, a novel cyclophilin inhibitor for the treatment of COVID-19.

Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide, today announced the promotion of Andrew Guggenhime from Chief Financial Officer and Chief Business Officer to President and Chief Financial Officer effective January 1, 2021

Quanta, Inc. (OTCPK:QNTA), today announced that it entered into a Securities Exchange Agreement in order to acquire 51% of Medolife Rx, Inc., a Wyoming corporation(“Medolife Rx”) in exchange for the issuance of newly created Preferred Stock, which upon closing,

RenovaCare, Inc. announced that it has issued the following year-end letter from its Chairman and CEO, Alan L. Rubino to the Company’s stockholders and interested parties:.

4C Medical Technologies, Inc. (4C Medical), a privately-held medical technology company focused on the development of minimally invasive technologies for structural heart disease, today announced it has completed an over-subscribed convertible note financing in which it has raised $10 million in gross proceeds.

Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, and Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, are pleased to announce a strategic commercial manufacturing agreement for the supply of DaxibotulinumtoxinA for Injection.

Boys & Girls Clubs of America and Thermo Fisher Scientific, the world leader in serving science, announced a partnership to make virtual STEM education programming available to millions of young people around the world.

DarioHealth Corp., a pioneer in the global digital therapeutics market, announced that the Company has entered into an agreement to provide its remote patient monitoring solution to Presbyterian Medical Services, one of the largest integrated healthcare systems in the State of New Mexico, effective January 1, 2021.

LogicBio Therapeutics, Inc. (Nasdaq: LOGC), a clinical stage genetic medicines company, today announced the appointment of Cecilia Jones as the Company’s chief financial officer, effective January 11, 2021.